Shares of MedAssets traded down 1.39% during mid-day trading on Wednesday, hitting $11.38. MedAssets has a one year low of $8.52 and a one year high of $14.58. The company has a market cap of $663.7 million and a P/E ratio of 1923.33.
MedAssets last issued its quarterly earnings data on Wednesday, May 2nd. The company reported $0.24 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.18 by $0.06. The company’s revenue for the quarter was up 14.9% on a year-over-year basis. Analysts expect that MedAssets will post $0.25 EPS next quarter.
A number of other analysts have also recently weighed in on MDAS. Analysts at Lazard Capital initiated coverage on shares of MedAssets in a research note to investors on Wednesday, May 23rd. They set a “buy” rating on the stock. Separately, analysts at Auriga reiterated a “buy” rating on shares of MedAssets in a research note to investors on Thursday, May 3rd. Finally, analysts at Auriga reiterated a “positive” rating on shares of MedAssets in a research note to investors on Thursday, April 5th.
MedAssets, Inc. provides technology-enabled products and services. These solutions are designed to improve operating margin and cash flow for hospitals and health systems.